Whitcomb & Hess’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Whitcomb & Hess's ABBV Position: Q3 2026 in Review
Whitcomb & Hess reduced its AbbVie (ABBV) stake by 0.21% in Q3 2026, selling an estimated $1.02K and leaving 1,897 shares worth $496K. The position accounts for 0.11% of the portfolio, ranked #41.
Whitcomb & Hess first reported a position in ABBV in Q4 2021 and has held it in 20 quarters since. 2,478 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Whitcomb & Hess held 1,897 shares of AbbVie worth $496K as of Q3 2026.
- Whitcomb & Hess sold 4 AbbVie shares in Q3 2026, an estimated $1.02K.
- AbbVie made up 0.11% of Whitcomb & Hess's portfolio in Q3 2026, its #41 holding.
- Whitcomb & Hess first reported a position in AbbVie in Q4 2021 and has held it in 20 quarters since.
- 2,478 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Whitcomb & Hess's 13F filing for Q3 2026, filed 7 Oct 2026.